CCTA ~ BREAST SHIELDS
RadiationBreast shield placement (randomized) among women.
Other names: BISMUTH BREAST SHIELDS
NCT Number: NCT02617888
Purpose
1. To investigate the effects of cardiac imaging radiation on the induction of DNA double-strand breaks by enumerating gamma-H2AX foci in blood lymphocytes and plucked hair follicle cells. 2. To estimate whether the use of breast shields in cardiac computed tomographic angiography (CCTA) limits the effective radiation exposure of breast tissue.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
The primary objective of the study is to analyze blood and hair samples from patients undergoing cardiac imaging to estimate radiation exposure levels as well as their biological effects (i.e. to determine the degree of genotoxicity by measuring the amounts of DNA double-strand breaks).
The secondary objective is to investigate whether the use of in-plane breast shielding in female patients undergoing CT angiography (CCTA) limits the radiation exposure of breast tissue and subsequent DNA damage in blood lymphocytes and hair follicle cells.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Breast shield placement (randomized) among women.
Other names: BISMUTH BREAST SHIELDS
Time frame: Change from baseline double strand DNA breaks at 30 minutes post-imaging
The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.
Walter Reed National Military Medical Center
Fed
The HEART BREAK Study: Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06154265
Arterial Occlusive Diseases, Arteriosclerosis
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06404515
ASCVD, Acute Coronary Syndrome
New York, United States
View Trial DetailsNCT06252350
Angina Pectoris, Arterial Occlusive Diseases
Grand Rapids, Michigan, United States
View Trial DetailsNCT00933400
Acute Coronary Syndrome, Acute Myocardial Infarction
Winston-Salem, North Carolina, United States
View Trial Details